Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation.

Chiang CH, Su Y, Wen Z, Yoritomo N, Ross CA, Margolis RL, Song H, Ming GL.

Mol Psychiatry. 2011 Apr;16(4):358-60. doi: 10.1038/mp.2011.13. Epub 2011 Feb 22. No abstract available.

2.

Stem cells: the magic brew.

Rossant J.

Nature. 2007 Jul 19;448(7151):260-2. No abstract available.

PMID:
17637646
3.

Functional roles of pluripotency transcription factors in mesenchymal stem cells.

Tsai CC, Hung SC.

Cell Cycle. 2012 Oct 15;11(20):3711-2. doi: 10.4161/cc.22048. Epub 2012 Sep 5. No abstract available.

4.

Claudin 6: a novel surface marker for characterizing mouse pluripotent stem cells.

Wang L, Xue Y, Shen Y, Li W, Cheng Y, Yan X, Shi W, Wang J, Gong Z, Yang G, Guo C, Zhou Y, Wang X, Zhou Q, Zeng F.

Cell Res. 2012 Jun;22(6):1082-5. doi: 10.1038/cr.2012.77. Epub 2012 May 8. No abstract available.

5.

Tapping an abundant resource: engineering pluripotent stem cells from blood.

Hofstetter C, Boockvar J.

Neurosurgery. 2010 Oct;67(4):N25. doi: 10.1227/01.neu.0000389740.23932.d1. No abstract available.

PMID:
20881549
6.

Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors.

Liao J, Wu Z, Wang Y, Cheng L, Cui C, Gao Y, Chen T, Rao L, Chen S, Jia N, Dai H, Xin S, Kang J, Pei G, Xiao L.

Cell Res. 2008 May;18(5):600-3. doi: 10.1038/cr.2008.51. No abstract available.

7.

Debugging cellular reprogramming.

Park IH, Daley GQ.

Nat Cell Biol. 2007 Aug;9(8):871-3. No abstract available.

PMID:
17671453
8.

Gene dynamics of core transcription factors for pluripotency in embryonic stem cells.

David BG, Okamoto K, Kakizuka T, Ichimura T, Watanabe TM, Fujita H.

J Biosci Bioeng. 2015 Apr;119(4):406-9. doi: 10.1016/j.jbiosc.2014.09.011. Epub 2014 Nov 3.

PMID:
25441442
9.

A diabetic milieu promotes OCT4 and NANOG production in human visceral-derived adipose stem cells.

Dentelli P, Barale C, Togliatto G, Trombetta A, Olgasi C, Gili M, Riganti C, Toppino M, Brizzi MF.

Diabetologia. 2013 Jan;56(1):173-84. doi: 10.1007/s00125-012-2734-7. Epub 2012 Oct 12.

PMID:
23064289
10.

[OCT4 and NANOG are the key genes in the system of pluripotency maintenance in mammalian cells].

Medvedev SP, Shevchenko AI, Mazurok NA, Zakiian SM.

Genetika. 2008 Dec;44(12):1589-608. Review. Russian.

PMID:
19178078
11.

Increased expression of the pluripotency markers sex-determining region Y-box 2 and Nanog homeobox in ovarian endometriosis.

Song Y, Xiao L, Fu J, Huang W, Wang Q, Zhang X, Yang S.

Reprod Biol Endocrinol. 2014 May 18;12:42. doi: 10.1186/1477-7827-12-42.

12.

Correlations between the levels of Oct4 and Nanog as a signature for naïve pluripotency in mouse embryonic stem cells.

Muñoz Descalzo S, Rué P, Garcia-Ojalvo J, Martinez Arias A.

Stem Cells. 2012 Dec;30(12):2683-91. doi: 10.1002/stem.1230.

13.

Induced pluripotent stem cells: what lies beyond the paradigm shift.

Cox JL, Rizzino A.

Exp Biol Med (Maywood). 2010 Feb;235(2):148-58. doi: 10.1258/ebm.2009.009267. Review.

14.

Rediscovering pluripotency: from teratocarcinomas to embryonic stem cells. Cardiff, 10-12 October 2011.

Barbaric I, Harrison NJ.

Int J Dev Biol. 2012;56(4):197-206. doi: 10.1387/ijdb.123503ib.

15.

The developmental dismantling of pluripotency is reversed by ectopic Oct4 expression.

Osorno R, Tsakiridis A, Wong F, Cambray N, Economou C, Wilkie R, Blin G, Scotting PJ, Chambers I, Wilson V.

Development. 2012 Jul;139(13):2288-98. doi: 10.1242/dev.078071.

16.

Expression of pluripotent stem cell markers in the human fetal testis.

Kerr CL, Hill CM, Blumenthal PD, Gearhart JD.

Stem Cells. 2008 Feb;26(2):412-21. Epub 2007 Nov 15.

17.

Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells.

Saiki Y, Ishimaru S, Mimori K, Takatsuno Y, Nagahara M, Ishii H, Yamada K, Mori M.

Ann Surg Oncol. 2009 Sep;16(9):2638-44. doi: 10.1245/s10434-009-0567-5. Epub 2009 Jun 25.

PMID:
19554373
18.

Co-localization of NANOG and OCT4 in human pre-implantation embryos and in human embryonic stem cells.

Hambiliki F, Ström S, Zhang P, Stavreus-Evers A.

J Assist Reprod Genet. 2012 Oct;29(10):1021-8. doi: 10.1007/s10815-012-9824-9. Epub 2012 Jun 29.

19.

Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells.

Buchholz DE, Hikita ST, Rowland TJ, Friedrich AM, Hinman CR, Johnson LV, Clegg DO.

Stem Cells. 2009 Oct;27(10):2427-34. doi: 10.1002/stem.189.

20.

Smad2 is essential for maintenance of the human and mouse primed pluripotent stem cell state.

Sakaki-Yumoto M, Liu J, Ramalho-Santos M, Yoshida N, Derynck R.

J Biol Chem. 2013 Jun 21;288(25):18546-60. doi: 10.1074/jbc.M112.446591. Epub 2013 May 6.

Supplemental Content

Support Center